WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
El Salvador's congress approves changes to reform constitution, a move critics call anti
Atletico Madrid battles Athletic Bilbao for 4th place in Spain and last Champions League berth
Third man is detained in a major bribery case that involves Russia's deputy defense minister
50 migrants reported missing and 9 rescued after their boat overturns off Spanish Atlantic island
Not every WNBA draft pick will make her team's roster. Here's why
What do weight loss drugs mean for a diet industry built on eating less and exercising more?
Convicted robber, 45, admits stabbing charity busker, 87, while riding his mobility scooter
Europeans share things about the American lifestyle that leave them absolutely baffled
The Latest: Trump takes to social media before Supreme Court arguments